| Title | Journal for ImmunoTherapy of Cancer |
| Abbreviation | J. ImmunoTher. Cancer |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Molecular Medicine (Q1); Oncology (Q1); Pharmacology (Q1) |
| h-index | 117 |
| Overall Rank/Ranking | 446 |
| SCImago Journal Rank (SJR) | 3.728 |
| Impact Score | 8.71 |
| Publisher | BMJ Publishing Group |
| Country | United Kingdom |
| ISSN | 20511426 |
| Best Quartile | Q1 |
| Coverage History | 2013-2023 |
Journal for ImmunoTherapy of Cancer is a journal covering the technologies/fields/categories related to Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Molecular Medicine (Q1); Oncology (Q1); Pharmacology (Q1). It is published by BMJ Publishing Group. The overall rank of Journal for ImmunoTherapy of Cancer is 446. According to SCImago Journal Rank (SJR), this journal is ranked 3.728. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 117. The best quartile for this journal is Q1.
The ISSN of Journal for ImmunoTherapy of Cancer journal is 20511426. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Journal for ImmunoTherapy of Cancer is cited by a total of 14743 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Journal for ImmunoTherapy of Cancer is 8.71, which is computed in 2024 as per its definition. Journal for ImmunoTherapy of Cancer IF is decreased by a factor of 0.17 and approximate percentage change is -1.91% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Journal for ImmunoTherapy of Cancer is 8.71. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 8.71 |
| 2022 | 8.88 |
| 2021 | 10.69 |
| 2020 | 11.40 |
| 2019 | 9.47 |
| 2018 | 8.00 |
| 2017 | 5.88 |
| 2016 | 5.18 |
| 2015 | 5.03 |
| 2014 | 2.24 |
Journal for ImmunoTherapy of Cancer has an h-index of 117. It means 117 articles of this journal have more than 117 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Journal for ImmunoTherapy of Cancer is 20511426. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Journal for ImmunoTherapy of Cancer is 446. According to SCImago Journal Rank (SJR), this journal is ranked 3.728. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 3.728 |
| 2022 | 3.403 |
| 2021 | 3.450 |
| 2020 | 5.060 |
| 2019 | 4.194 |
| 2018 | 3.337 |
| 2017 | 2.798 |
| 2016 | 2.668 |
| 2015 | 1.929 |
| 2014 | 0.486 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 446 |
| 2022 | 494 |
| 2021 | 475 |
| 2020 | 285 |
| 2019 | 359 |
| 2018 | 546 |
| 2017 | 739 |
| 2016 | 807 |
| 2015 | 1547 |
| 2014 | 9184 |
Journal for ImmunoTherapy of Cancer is published by BMJ Publishing Group. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2013-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Journal for ImmunoTherapy of Cancer is J. ImmunoTher. Cancer. This abbreviation ('J. ImmunoTher. Cancer') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Molecular Medicine (Q1); Oncology (Q1); Pharmacology (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Journal for ImmunoTherapy of Cancer latest impact IF is 8.71. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 11.40 (2020) and 2.24 (2014), respectively, in the last 10 years. Moreover, its average IS is 7.55 in the previous 10 years.
The Journal for ImmunoTherapy of Cancer has an SJR (SCImago Journal Rank) of 3.728, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 5.060 in 2020 and the lowest being 0.486 in 2014. Furthermore, the average SJR of the Journal for ImmunoTherapy of Cancer over the previous 10-year period stands at 7.55.
The latest h-index of the Journal for ImmunoTherapy of Cancer is 117.
The Journal for ImmunoTherapy of Cancer is published by the BMJ Publishing Group, with its country of publication being the United Kingdom.
The Journal for ImmunoTherapy of Cancer is currently ranked 446 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 285 in 2020 and its lowest position of 9184 in 2014.
The standard ISO4 abbreviation for the Journal for ImmunoTherapy of Cancer is J. ImmunoTher. Cancer.
Journal for ImmunoTherapy of Cancer is classified as a journal that the BMJ Publishing Group publishes.
The Journal for ImmunoTherapy of Cancer encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Journal for ImmunoTherapy of Cancer is assigned the following International Standard Serial Numbers (ISSN): 20511426.
The best quartile for the Journal for ImmunoTherapy of Cancer is Q1 (2023).
The Journal for ImmunoTherapy of Cancer coverage history can be summarized as follows: 2013-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| European Union Politics | journal | 2569 | SAGE Publications Ltd | 75 | 3.24 |
| SPE Production and Operations Symposium, Proceedings | conference and proceedings | 15907 | 21 | 0.00 | |
| Milan Journal of Mathematics | journal | 3538 | Birkhauser Verlag Basel | 29 | 1.14 |
| Journal of International Financial Management and Accounting | journal | 1921 | Wiley-Blackwell Publishing Ltd | 45 | 9.38 |
| Air and Space Power Journal (discontinued) | journal | 28397 | AU Press | 9 | 0.20 |
| Marine Biology Research | journal | 14120 | Taylor and Francis Ltd. | 45 | 1.02 |
| Journal, Indian Academy of Clinical Medicine | journal | 26979 | Indian Academy of Clinical Medicine | 16 | 0.10 |
| Libyan Studies | journal | 19526 | Cambridge University Press | 9 | 0.30 |
| Archives of the Balkan Medical Union | journal | 23592 | Balkan Medical Union | 12 | 0.21 |
| Epigenetics | journal | 3529 | Landes Bioscience | 111 | 3.22 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 8.71 |
| 2022 | 8.88 |
| 2021 | 10.69 |
| 2020 | 11.40 |
| 2019 | 9.47 |
| 2018 | 8.00 |
| 2017 | 5.88 |
| 2016 | 5.18 |
| 2015 | 5.03 |
| 2014 | 2.24 |
